SCHEMBL3081385

SCHEMBL3081385

CCOC(=O)/C=C/c1ccc(Sc2cccc(OCc3ccccc3)c2)cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB2 P05107 1/20 0.44
ICAM1 P05362 1/20 0.44
ITGAL P20701 1/20 0.44
S1PR1 P21453 1/20 0.44
MEN1 O00255 1/20 0.44
HSP90AA1 P07900 1/20 0.44
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
PKM P14618 1/20 0.43
HDAC8 Q9BY41 1/20 0.42
MAOB P27338 1/20 0.41
NMT1 P30419 3/20 0.40
NMT2 O60551 1/20 0.40
MAPT P10636 1/20 0.40
NR4A2 P43354 1/20 0.40
PPARG P37231 1/20 0.40
PPARD Q03181 1/20 0.40
PPARA Q07869 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3081386 1.00 ITGB2 (0.44) ITGB2ICAM1ITGALS1PR1MEN1
SCHEMBL6031320 0.88 KDM4E (0.57) ITGB2ICAM1ITGALS1PR1ALDH1A1
SCHEMBL6031317 0.88 KDM4E (0.57) ITGB2ICAM1ITGALS1PR1ALDH1A1
SCHEMBL15669061 0.87 MEN1 (0.54) MEN1HSP90AA1KMT2AALDH1A1HDAC8
SCHEMBL15669064 0.87 MEN1 (0.54) MEN1HSP90AA1KMT2AALDH1A1HDAC8
SCHEMBL13179954 0.86 ALOX5 (0.42) MEN1KMT2AHDAC8MAPTPPARG
SCHEMBL3115040 0.85 MEN1 (0.48) MEN1HSP90AA1KMT2AALDH1A1KDM4E
SCHEMBL3303621 0.85 PTGS2 (0.42) ITGALMEN1KMT2AALDH1A1MAPT
SCHEMBL3303627 0.85 PTGS2 (0.42) ITGALMEN1KMT2AALDH1A1MAPT
SCHEMBL3085911 0.80 MAOB (0.52) ITGB2ICAM1ITGALS1PR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1806338-B1 PROCESS FOR PRODUCING 2-AMINO-2-[2-[4-(3-BENZYLOXY-PHENYLTHIO)-2-CHLOROPHENYL[ETHYL]-1,3-PROPANEDIOL HYDROCHLORIDE AND HYDRATES THEREOF. AND INTERMEDIATES THE PRODUCTION THEREOF KYORIN SEIYAKU KK (JP) 2016-01-20 EP claimed
US-7795472-B2 Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride and hydrates thereof, and intermediates in the production thereof KYORIN PHARMACEUTICAL CO., LTD. (JP) 2010-09-14 US claimed
US-20080207941-A1 Process for Producing 2-Amino-2-[2-[4-(3-Benzyloxyphenylthio)-2-Chlorophenyl]Ethyl]-1,3-Propanediol Hydrochloride and Hydrates Thereof, and Intermediates in the Production Thereof KYORIN PHARMACEUTICAL CO., LTD. (JP) 2008-08-28 US claimed
EP-1806338-A1 PROCESS FOR PRODUCING 2-AMINO-2-[2-[4-(3-BENZYLOXY­PHENYLTHIO)-2-CHLOROPHENYL[ETHYL]-1,3-PROPANEDIOL HYDROCHLORIDE OR HYDRATE THEREOF AND INTERMEDIATE FOR THE SAME Kyorin Pharmaceutical Co., Ltd. (JP) 2007-07-11 EP claimed
EP-2511262-B1 PROCESS FOR PRODUCING 2-AMINO-2-[2-[4-(3-BENZYLOXY-PHENYLTHIO)-2-CHLOROPHENYL[ETHYL]-1,3-PROPANEDIOL HYDROCHLORIDE KYORIN SEIYAKU KK (JP) 2017-02-01 EP disclosed
EP-2511262-B1 PROCESS FOR PRODUCING 2-AMINO-2-[2-[4-(3-BENZYLOXY-PHENYLTHIO)-2-CHLOROPHENYL[ETHYL]-1,3-PROPANEDIOL HYDROCHLORIDE KYORIN SEIYAKU KK (JP) 2017-02-01 EP disclosed
EP-1806338-B1 PROCESS FOR PRODUCING 2-AMINO-2-[2-[4-(3-BENZYLOXY-PHENYLTHIO)-2-CHLOROPHENYL[ETHYL]-1,3-PROPANEDIOL HYDROCHLORIDE AND HYDRATES THEREOF. AND INTERMEDIATES THE PRODUCTION THEREOF KYORIN SEIYAKU KK (JP) 2016-01-20 EP disclosed
CN-101880250-B Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same KYORIN SEIYAKU KK 2013-04-03 CN disclosed
EP-2511262-A1 PROCESS FOR PRODUCING 2-AMINO-2-[2-[4-(3-BENZYLOXY-PHENYLTHIO)-2-CHLOROPHENYL[ETHYL]-1,3-PROPANEDIOL HYDROCHLORIDE Kyorin Pharmaceutical Co., Ltd. (JP) 2012-10-17 EP disclosed
CN-101072752-B Method for producing 2-amino-2- [2- [4- (3-benzyloxyphenylthio) -2-chlorophenyl ] ethyl ] -1, 3-propanediol hydrochloride or hydrate thereof and intermediate for producing same KYORIN SEIYAKU KK 2010-12-08 CN disclosed
US-7795472-B2 Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride and hydrates thereof, and intermediates in the production thereof KYORIN PHARMACEUTICAL CO., LTD. (JP) 2010-09-14 US disclosed
US-7795472-B2 Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride and hydrates thereof, and intermediates in the production thereof KYORIN PHARMACEUTICAL CO., LTD. (JP) 2010-09-14 US disclosed
US-20080207941-A1 Process for Producing 2-Amino-2-[2-[4-(3-Benzyloxyphenylthio)-2-Chlorophenyl]Ethyl]-1,3-Propanediol Hydrochloride and Hydrates Thereof, and Intermediates in the Production Thereof KYORIN PHARMACEUTICAL CO., LTD. (JP) 2008-08-28 US disclosed
US-20080207941-A1 Process for Producing 2-Amino-2-[2-[4-(3-Benzyloxyphenylthio)-2-Chlorophenyl]Ethyl]-1,3-Propanediol Hydrochloride and Hydrates Thereof, and Intermediates in the Production Thereof KYORIN PHARMACEUTICAL CO., LTD. (JP) 2008-08-28 US disclosed
CN-101072752-A Method for producing 2-amino-2- [ 2- [ 4- (3-benzyloxyphenylthio) -2-chlorophenyl ] ethyl ] -1, 3-propanediol hydrochloride or hydrate thereof and intermediate for producing same KYORIN SEIYAKU KK (JP) 2007-11-14 CN disclosed
EP-1806338-A1 PROCESS FOR PRODUCING 2-AMINO-2-[2-[4-(3-BENZYLOXY­PHENYLTHIO)-2-CHLOROPHENYL[ETHYL]-1,3-PROPANEDIOL HYDROCHLORIDE OR HYDRATE THEREOF AND INTERMEDIATE FOR THE SAME Kyorin Pharmaceutical Co., Ltd. (JP) 2007-07-11 EP disclosed
EP-1806338-A1 PROCESS FOR PRODUCING 2-AMINO-2-[2-[4-(3-BENZYLOXY­PHENYLTHIO)-2-CHLOROPHENYL[ETHYL]-1,3-PROPANEDIOL HYDROCHLORIDE OR HYDRATE THEREOF AND INTERMEDIATE FOR THE SAME Kyorin Pharmaceutical Co., Ltd. (JP) 2007-07-11 EP disclosed
WO-2006041019-A1 PROCESS FOR PRODUCING 2-AMINO-2-[2-[4-(3-BENZYLOXY­PHENYLTHIO)-2-CHLOROPHENYL]ETHYL]-1,3-PROPANEDIOL HYDROCHLORIDE OR HYDRATE THEREOF AND INTERMEDIATE FOR THE SAME KYORIN PHARMACEUTICAL CO., LTD. (JP) 2006-04-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207941-A1 Process for Producing 2-Amino-2-[2-[4-(3-Benzyloxyphenylthio)-2-Chlorophenyl]Ethyl]-1,3-Propanediol Hydrochloride and Hydrates Thereof, and Intermediates in the Production Thereof NAT1, ACR, NOD1 ITGB2 3078/4885ICAM1 436/4885ITGAL 4519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.